Glutamate release inhibition ineffective in levodopa-induced motor complications

被引：24

作者：

Bara-Jimenez, William ^{[1
]}

Dimitrova, Tzvetelina D. ^{[1
]}

Sherzai, Abdullah ^{[1
]}

Aksu, Murat ^{[1
]}

Chase, Thomas N. ^{[1
]}

机构：

[1] NINDS, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA

来源：

MOVEMENT DISORDERS | 2006年 / 21卷 / 09期

关键词：

glutamate; riluzole; dopamine; Parkinson's disease; dyskinesias; levodopa; striatum;

D O I：

10.1002/mds.20976

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Reported benefits of various glutamatergic receptor antagonists in Parkinson's disease (PD) prompted an evaluation of the antidyskinetic effect of a putative glutamate release inhibitor in 15 moderately advanced patients. In a 3-week, double-blind, proof-of-concept study, riluzole (200 mg/day) failed to alter parkinsonian or levodopa-induced motor complication severity. Opposing effects of a generalized inhibition of glutamate-mediated synaptic transmission may limit the usefulness of this approach to treat PD. (c) 2006 Movement Disorder Society.

引用

页码：1380 / 1383

页数：4

共 22 条

[21] Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsoman monkeys [J].

Tahar, AH ;

Grégoire, L ;

Darré, A ;

Bélanger, N ;

Meltzer, L ;

Bédard, PJ .

NEUROBIOLOGY OF DISEASE, 2004, 15 (02) :171-176

[22] Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse [J].

Valenti, O ;

Marino, MJ ;

Wittmann, M ;

Lis, E ;

DiLella, AG ;

Kinney, GG ;

Conn, PJ .

JOURNAL OF NEUROSCIENCE, 2003, 23 (18) :7218-7226

← 1 2 3 →